HLA‐B* 2707 is associated with ankylosing spondylitis in most populations. Like the non‐
associated allotypes B* 2706 and B* 2709, it lacks Asp116 and shows preference for …

The peptide specificity of HLA-B* 1403, an allotype associated with ankylosing spondylitis
(Lopez-Larrea, C., Mijiyawa, M., Gonzalez, S., Fernandez-Morera, JL, Blanco-Gelaz, MA …

B* 2704 and B* 2706 are two closely related HLA‐B27 subtypes, which differ from the
common B* 2705 by the Asp> Ser77, Val> Glu152, and Ala> Gly211 amino acid changes. In …

B* 2704 and B* 2706 are closely related HLA–B27 subtypes of which the former but not the
latter is associated to ankylosing spondylitis. Their peptide specificity relative to other …

Abstract HLA-B* 2702, B* 2704, and B* 2705 are strongly associated with spondyloarthritis,
whereas B* 2706 is not. Subtypes differ among each other by a few amino acid changes and …

HLA-B* 2705 is strongly associated with ankylosing spondylitis (AS) and reactive arthritis. In
contrast, B* 2709 has been reported to be more weakly or not associated to AS. These two …

HLA-B* 2704 is strongly associated with ankylosing spondylitis. B* 2706, which differs from
B* 2704 by two amino acid changes, is not associated with this disease. A systematic …

HLA‐B* 2702 is an ankylosing spondylitis‐associated allotype that differs from the more
common B* 2705 at residues 77, 80, and 81, in the peptide‐binding site. The diversity and …

Objective To investigate the rules governing peptide binding to HLA–B* 2705, and to B*
2704 and B* 2706, which are 2 subtypes differentially associated with ankylosing …

In contrast to HLA-B* 2705, B* 2709 is weakly or not associated to ankylosing spondylitis.
Both allotypes differ by a single D116H change. We compared the B* 2705-and B* 2709 …